Carotid Artery Stenting: JACC State-of-the-Art Review

Christopher J. White, Thomas G. Brott, William A. Gray, Donald Heck, Tudor Jovin, Sean P. Lyden, David Christopher Metzger, Kenneth Rosenfield, Gary Roubin, Ravish Sachar, Adnan Siddiqui

Research output: Contribution to journalReview articlepeer-review


Significant advances in the field of carotid artery stenting (CAS) have occurred, including new randomized trial data, recent professional societal statements for competency, new techniques and new devices that have been developed, and perhaps most importantly, our understanding of how to better select candidates for CAS to avoid periprocedural complications. The current Centers for Medicare and Medicaid Services coverage decision regarding CAS is outdated, and our review supports our recommendation to approve CAS in selected candidates who are symptomatic with a carotid stenosis ≥50% and ≤99% and for asymptomatic patients with carotid stenosis ≥70% and ≤99% for stroke prevention. Optimized CAS strategies have allowed experienced operators to better assess procedure risk before CAS and have led to continued improvement in CAS outcomes. New technologies including enhanced embolic protection devices and dual-layered stents should result in further improvement.

Original languageEnglish (US)
Pages (from-to)155-170
Number of pages16
JournalJournal of the American College of Cardiology
Issue number2
StatePublished - Jul 12 2022


  • carotid angioplasty
  • carotid endarterectomy
  • embolic protection
  • stroke prevention

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'Carotid Artery Stenting: JACC State-of-the-Art Review'. Together they form a unique fingerprint.

Cite this